Autoinducer molecule
US6936447B1 · kind B1 · utility
4Cited by
10References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 3, 2000 |
| Grant date | Aug 30, 2005 |
| Priority date | — |
| Expiry date | Apr 3, 2020 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/875
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Autoinducer molecules, e.g., N-(3-oxododecanoyl)homoserine lactone, for Pseudomonas aeruginosa are described. The molecules regulate gene expression in the bacterium. Therapeutic compositions and therapeutic methods involving analogs and/or inhibitors of the autoinducer molecules also are described. The molecules are useful for treating or preventing infection by Pseudomonas aeruginosa.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.